Our Founder Prof Thomas Helleday wins the Anders Jahre’s price in Medicine

by admin
augusti 15, 2024

Read the article here.

Rekommenderade artiklar

One-carbon Therapeutics Announces Strategic Collaboration with Tempus to Advance Molecular Insights and Enable Precision Oncology Development of TH9619

Solna, Sweden, March 17h, 2026. One-carbon Therapeutics, a clinical-stage oncology

One-carbon Therapeutics announces oversubscribed private placement financing of SEK 153 million (€13.9 million)

Solna, Sweden, December 1, 2025. One-carbon Therapeutics AB, a clinical-stage

One-carbon Therapeutics AB Announces First Subject Dosed in the ODIN Phase 1/2 Clinical Study of TH9619 in Advanced Solid Tumors

Stockholm, Sweden. November 17th, 2025. One-carbon Therapeutics AB, a clinical-stage biotechnology